Whole Genome Analysis for improved healthcare

Quality

genomiQa’s analysis software and processes have been developed and refined with quality as a guiding principle. They have been established using our research experience which has been published in top-tier peer-reviewed scientific journals such as Nature. Ask us how we can help check the quality of your NGS output!

Get in touch

Analytics

genomiQa’s analysis pipelines are flexible, custom-made and customisable. We specialise in somatic and germline analysis of whole genome, whole exome and RNA sequencing. Get in touch

Clinical Trials

genomiQa can work with you to add genomics to your clinical trials and support the analysis for greater insights - Pharmacogenomics Get in touch

Data

genomiQa has extensive experience interpreting many data sets, working with "classifiers" to unlock insights, and adding value to your data Get in touch

About

genomiQa is a start-up company originating from QIMR Berghofer Medical Research Institute’s SEEDBox® initiative, which prepares promising research for commercialisation. genomiQa will offer hospitals, clinicians and pharma companies high-quality analysis of data from whole genome sequencing

Partnerships

genomiQa has an interest in establishing strong long-term strategic partnerships with: global sequencing providers; hospitals looking to implement clinical genomics; allied health professionals and companies that deliver clinical genomics in cancer.

Get in touch

Meet the team

Nic Waddell, PhD

Founder

Founder and Head of the Medical Genomics research group at QIMR Berghofer. Leader in the interpretation of next generation sequence data, with multiple Nature publications. Her ongoing research focuses on the identification of mutational processes and therapeutic opportunity in a variety of cancer types, with a goal to have quality genomics implemented into the clinic.

John Pearson

Founder

Founder and Leader of the Genome Informatics group at QIMR Berghofer. He has created software for medical researchers and has developed analysis pipelines for whole genome, exome and panel sequencing. He has worked with next-generation sequencing projects in the USA and Australia and has been involved in the 1000 Genomes Project and the International Cancer Genome Consortium (ICGC).

Colin Albert

CEO

Colin joins genomiQa with the ambition to establish it as a world leader in whole genome analysis. This will be achieved by using his global experience in start ups and launching new products, which included three years based in Shanghai, China. Most recently Colin was the Commercial Director for Roche Pharmaceuticals - APAC and the Regional General Manager - Roche Foundation Medicine - APAC based in Singapore.

Get in touch

Get in touch and we’ll get back to you as promptly as possible.

* required fields